FSFernando Mendes Sant'ANna

Fernando Mendes Sant'ANna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fernando Mendes Sant'ANna has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A case-based narrative review of the diagnostic approach to central nervous system demyelinating disorders

    by Lucas Bonacossa Sant'ANna, Igor Martins Moreira, João Éder Ribeiro Tuler, Mariana Bonacossa Sant'ANna, Helena Carvalho Boechat, Camile Torres Andriani, Victoria Depes Scaramussa, Fernando Mendes Sant’ANna, Eliane Almeida Do Valle, Eduardo Xavier Hias Pozzobon, et al.

    Central nervous system demyelinating disorders (CNS-DD) can cause abrupt, disabling, yet potentially reversible neurologic deficits; rapid recognition is essential because acute immunotherapy is time-sensitive. This narrative review, anchored in a three-patient case series, outlines a practical diagnostic workflow to differentiate the main inflammatory demyelinating syndromes. We describe: (1) multiple sclerosis in a 23-year-old man with optic neuritis, typical brain MRI lesions, and cerebrospinal fluid oligoclonal bands fulfilling McDonald criteria; (2) aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder in a 24-year-old woman with longitudinally extensive myelitis, optic symptoms, and area postrema syndrome; and (3) MOG antibody-associated disease in a 23-year-old postpartum woman with ADEM-like encephalopathy and strongly positive serum MOG-IgG. Across entities, lesion topography on brain/spine MRI, CSF profile, and serum antibody testing (AQP4-IgG, MOG-IgG) are pivotal to exclude mimics and guide early treatment.

  • Open Access

    Infective endocarditis due to cardiac pacemaker infection

    by Lucas Bonacossa Sant'ANna, Igor Martins Moreira, Helena Carvalho Boechat, Camile Torres Andriani, Victoria Depes Scaramussa, Mariana Bonacossa Sant’ANna, Eliane Almeida Do Valle, Eduardo Xavier Hias Pozzobon, Fernando Mendes Sant'ANna, Aloysio Guimarães da Fonseca

    Introduction: Infective endocarditis (IE) related to cardiac implantable electronic devices (CIED) is rare but potentially fatal, and may compromise the generator, leads, or cardiac valves. Most cases occur in multimorbid patients and are caused by Staphylococcus aureus or S. epidermidis. Case report: An elderly patient with a dual-chamber pacemaker implanted four years earlier was admitted with sepsis, fever, and acute kidney injury. On examination, exposure of the generator unit with purulent discharge was noted. Echocardiography showed vegetations on the ventricular lead and the right atrial wall, and blood cultures were positive for S. aureus. Computed tomography revealed multiple cavitary nodules compatible with septic emboli. Device extraction was performed, followed by pathogen-directed antibiotic therapy for four weeks, with favorable progression and hospital discharge without sequelae. Conclusion: CIED-related IE requires rapid diagnosis and aggressive management. Microbiological confirmation, early detection of complications, and device removal combined with appropriate antibiotics were decisive for the favorable outcome.

  • Open Access

    Newly diagnosed Crohn's Disease after COVID-19 Infection: A Case Report

    by Lucas Bonacossa Sant'ANna, Mariana Bonacossa Sant'ANna, Eduardo Amar Ferreira, Aloysio Guimarães da Fonseca, Fernando Mendes Sant'ANna, Ana Teresa Pugas Carvalho

    Viral infections are recognized as potential triggers for immune-mediated diseases, and an increasing number of reports have described newly diagnosed inflammatory bowel disease (IBD) following COVID-19. We report a previously healthy 23-year-old man who was diagnosed with Crohn’s disease (CD) shortly after symptomatic SARS-CoV-2 infection. Within two weeks of the confirmed infection, he developed severe gastrointestinal symptoms, followed by a perianal abscess and fistulizing disease. Ileocolonoscopy revealed patchy erosive colitis with predominant rectosigmoid involvement, while histological examination demonstrated chronic active granulomatous ileocolitis. He required surgical drainage, corticosteroids, azathioprine, and ultimately infliximab, achieving complete mucosal healing within one year. A literature review identified 19 previously reported cases of newly diagnosed IBD following COVID-19, most of which were ulcerative colitis; none of the reported CD cases presented with perianal fistulizing disease or required anti-TNF therapy. Proposed pathophysiological links between COVID-19 and IBD include altered epithelial ACE2 expression, gut dysbiosis, barrier disruption, and post-infectious immune dysregulation, providing biological plausibility for a possible association. This rare case of severe, newly diagnosed CD temporally associated with COVID-19 highlights the need to investigate persistent gastrointestinal symptoms after infection, although causality and the possibility of previously subclinical disease cannot be established from a single case.

  • Open Access

    Será a Ablação por Cateter para Fibrilação Atrial em Pacientes com Insuficiência Cardíaca e Fração de Ejeção Reduzida uma Boa Opção Terapêutica?

    by Sergio Menezes Couceiro, Fernando Mendes Sant'ANna

    O artigo foi bem escrito, interessante, tem relevância e validade e teve como objetivo comparar resultados obtidos através de metanálises de ensaios randomizados controlados sobre ablação por cateter em pacientes com fração de ejeção do ventrículo esquerdo inferior a 45%., Os métodos utilizados foram interessantes e procuraram responder à questão principal. Eles buscaram na literatura estudos que comparassem ablação por cateter (AC) com terapia médica em pacientes com fibrilação atrial (FA) com (fração de ejeção do ventrículo esquerdo) FEVE ≤45%.


  • Open Access

    Acupuncture in cancer care: a narrative review

    by André Wan Wen Tsai, Eduardo D'ALessandro, Sidney Brandão, João Bosco Guerreiro, Ricardo Morad Bassetto, Janete Shatkoski Bandeira, Marcus Yu Bin Pai, Adriano Höhl, Alexandre Valotta da Silva, Fernando Mendes Sant'ANna

    Cancer is the main public health problem worldwide, being one of the main causes of death and, consequently, one of the main barriers to the increase in life expectancy1 1 Santos MO, Lima FCS, Martins LFL, Oliveira JFP, Almeida LM, Cancela MC. Estimativa de incidência de câncer no Brasil, 2023-2025. Rev Bras Cancerol. 2023;69(1):e-213700. https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700 https://doi.org/10.32635/2176-9745.RBC.2... . The impact of cancer, based on estimates by the Global Cancer Observatory (Globocan)2 2 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660 https://doi.org/10.3322/caac.21660... , prepared by the International Agency for Research on Cancer (IARC), points out that there were 19.3 million new cases of cancer in 2020 worldwide. One in five individuals will have cancer during their lifetime2 2 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660 https://doi.org/10.3322/caac.21660... ,3 3 Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. https://doi.org/10.1002/ijc.33588 https://doi.org/10.1002/ijc.33588... . Notably, 10 main types of cancer represent more than 60% of all new cases. Female breast cancer is the most common cancer worldwide, with 2.3 million (11.7%) new cases, followed by lung cancer, with 2.2 million (11.4%); colon and rectum, with 1.9 million (10.0%); prostate, with 1.4 million (7.3%); and non-melanoma skin, with 1.2 million (6.2%) new cases. In Brazil, the estimate for the 3-year period from 2023 to 2025 indicates that there will be 704,000 new cases of cancer, 483,000 if cases of non-melanoma skin cancer are excluded1 1 Santos MO, Lima FCS, Martins LFL, Oliveira JFP, Almeida LM, Cancela MC. Estimativa de incidência de câncer no Brasil, 2023-2025. Rev Bras Cancerol. 2023;69(1):e-213700. https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700 https://doi.org/10.32635/2176-9745.RBC.2... .


  • Open Access

    É Hora de Revisitar os Limites da Reserva de Fluxo Fracionada?

    by Fernando Mendes Sant’aNna, Lucas Bonacossa Sant’aNna, Sérgio Lívio Menezes Couceiro

    A avaliação fisiológica intracoronária é estabelecida como uma estratégia valiosa para identificar estenoses epicárdicas limitantes de fluxo em pacientes com doença arterial coronariana (DAC) e para determinar uma indicação para intervenções coronárias percutâneas (ICP). Supunha-se anteriormente que, uma vez que a doença limitante do fluxo fosse confirmada por uma medida com fio-guia de pressão, a ICP guiada por angiografia deveria levar à restauração efetiva da condutância do vaso. No entanto, estudos com avaliação fisiológica pós-ICP com base na reserva de


  • Open Access

    Melhorando as Metanálises

    by Fernando Mendes Sant’aNna, Mariana Bonacossa Sant’aNna, Lucas Bonacossa Sant’aNna

    A metanálise (MA) de Meng-jin et al., publicada nesta edição da revista, traz informações importantes sobre o tratamento invasivo de pacientes idosos (≥ 75 anos) com infarto agudo do miocárdio sem supradesnivelamento do segmento ST (IAMSSST) versus tratamento conservador. Mesmo ciente dos benefícios da revascularização precoce em pacientes idosos e jovens, no primeiro grupo, sabe-se que a preocupação com os riscos de complicações em procedimentos invasivos reduz o número de intervenções nesse grupo. Por outro lado, com o rápido crescimento

  • Open Access

    Neuromodulação Vagal Auricular e sua Aplicabilidade em Pacientes com Insuficiência Cardíaca e Fração de Ejeção Reduzida

    by Sergio Menezes Couceiro, Lucas Bonacossa Sant’aNna, Mariana Bonacossa Sant’aNna, Renata S. Matos Menezes, Evandro Tinoco Mesquita, Fernando Mendes Sant’aNna

    Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min, [...] Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min,


  • Open Access

    Non-hyperemic pressure ratios – theoretical basis, clinical applications, and limitations

    by Daniel Chamié, Júlio de Paiva Maia, Tales Raminho, Lara Eurípedes, Lucas Bonacossa Sant’anna, Adriano Caixeta, Fernando Mendes Sant’anna

    Coronary physiology has become the standard of care to assess the functional significance of coronary atherosclerotic disease. It allows for identification of myocardial ischemia on a vessel level, discrimination of the functional patterns of atherosclerotic disease, guidance for the need of revascularization, complements the planning of percutaneous coronary intervention and verification of the functional success of percutaneous coronary intervention. On a previous issue of the Journal of Transcatheter Interventions, we presented a comprehensive review about fractional flow reserve. Despite [...] ABSTRACT Coronary physiology has become the standard of care to assess the functional significance of coronary atherosclerotic disease. It allows for identification of myocardial ischemia on a vessel level, discrimination of the functional patterns of atherosclerotic disease, guidance for the need of revascularization, complements the planning of percutaneous coronary intervention and verification of the functional success of percutaneous coronary intervention. On a previous issue of the Journal of Transcatheter Interventions, we presented a comprehensive review about fractional flow reserve. Despite

  • Open Access

    Auricular vagus nerve stimulation: a new option to treat inflammation in COVID-19?

    by Fernando Mendes Sant’aNna, Rodrigo César Lima Resende, Lucas Bonacossa Sant’aNna, Sérgio Lívio Menezes Couceiro, Romero Bonacossa Soares Pinto, Mariana Bonacossa Sant’aNna, Liaw Wen Chao, Jozsef Constantin Szeles, Eugenijus Kaniusas

    COVID-19 is an infectious disease caused by the new coronavirus (SARS-CoV-2), which invades alveolar epithelial cells through angiotensin-2 converting enzyme (ACE2) receptors1 1 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 https://doi.org/10.1016/j.cell.2020.02.0... ,2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... . Infection is triggered by the binding of the spike protein (S) of SARS-CoV-1 or SARS-CoV-2 to ACE23 3 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805-16. https://doi.org/10.36660/abc.20200279 https://doi.org/10.36660/abc.20200279... and, through this binding, the virus enters the host cell, where ACE2 is later inactivated. As this enzyme is abundantly found in alveolar epithelial cells and in the myocardium, potentially serious damage can occur in the lungs and heart2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... ,4 4 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 https://doi.org/10.1016/j.scitotenv.2020... .